Daily Archives: February 2, 2023 | LinksMedicus Free Medical News & Perspectives

? Just launched!

? @ilo report finds that reduced working hours and more flexible working time arrangements can benefit economies, enterprises and workers, and lay the ground for a better work-life balance.https://t.co/OMRlFJZCZL

— International Labour Organization (@ilo) January 6, 2023

Efficacy, safety, and tolerability of antidepressants for pain in adults: overview of systematic reviews

2 Feb, 2023 | 15:05h | UTC

Efficacy, safety, and tolerability of antidepressants for pain in adults: overview of systematic reviews – The BMJ

Editorial: Rethinking use of medicines for chronic pain – The BMJ

News Release: Antidepressants use for chronic pain on the rise, but are they effective? – University of Sidney

Commentary from the author on Twitter (thread – click for more)

Out today in @bmj_latest

We reviewed the evidence on the efficacy of antidepressants for pain in adults

We showed that antidepressants are effective for some pain conditions, but for most they are either ineffective or evidence is inconclusivehttps://t.co/E2XVQ9oGUQ
? pic.twitter.com/kBo7eAyeCP

— Giovanni Ferreira (@giovanni_ef) February 1, 2023

RCT | Remifentanil vs. neuromuscular blockers during rapid sequence intubation in patients at risk of aspiration

2 Feb, 2023 | 15:01h | UTC

Effect of Remifentanil vs Neuromuscular Blockers During Rapid Sequence Intubation on Successful Intubation Without Major Complications Among Patients at Risk of Aspiration: A Randomized Clinical Trial – JAMA (link to abstract – $ for full-text)

Commentary on Twitter

Among adults at risk of aspiration during rapid sequence intubation in the operating room, remifentanil, vs neuromuscular blockers, did not meet the criterion for noninferiority w regard to successful intubation on first attempt w/o major complications. https://t.co/ENvKxI7Oef

— JAMA (@JAMA_current) January 3, 2023

Review | Current and emerging knowledge of diagnostic imaging in COVID-19

2 Feb, 2023 | 15:04h | UTC

Current and Emerging Knowledge in COVID-19 – Radiology

Patients labeled as nonallergic after initial tests for penicillin allergy may develop resensitization afterwards

2 Feb, 2023 | 15:03h | UTC

Resensitization in suspected penicillin allergy – Allergy

Video summary: Resensitisation in suspected penicillin allergy

Commentary: Patients should be retested for penicillin resensitization before being deemed nonallergic – Healio (free registration required)

Improving antimicrobial stewardship with penicillin allergy testing: a review of current practices and unmet needs – JAC-Antimicrobial Resistance

Management of Patients with Suspected or Confirmed Antibiotic Allergy. Executive Summary of Guidance from the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC), the Spanish Society of Allergy and Clinical Immunology (SEAIC), the Spanish Society of Hospital Pharmacy (SEFH) and the Spanish Society of Intensive Medicine and Coronary Care Units (SEMICYUC) – Journal of Investigational Allergology and Clinical Immunology (PDF)

The prevalence of penicillin allergy labeling ranged from 0.9% to 10.2% across practices in a large pediatric cohort, raising questions regarding the validity of those labels and the unnecessary use of second-line antibiotics that may follow.

M-A: Most patients with allergy to Penicillin can be given Cefazolin

Systematic review: Safety and efficacy of de-labelling penicillin allergy in adults using direct oral challenge

Penicillin allergy labels increase second-line broad-spectrum antibiotic prescribing for pediatric respiratory tract infections

Podcast: A Clinical Pharmacologist’s Perspective on Penicillin Allergy

Study: Development and Validation of a Penicillin Allergy Clinical Decision Rule

Management of a surgical patient with a label of penicillin allergy: narrative review and consensus recommendations – British Journal of Anaesthesia

NICE: Double Check Patients with ‘Penicillin Allergy’ to Avoid Increased MRSA Risk

Cohort Study: Risk of Meticillin Resistant Staphylococcus Aureus and Clostridium Difficile in Patients with a Documented Penicillin Allergy

Commentary on Twitter

Doña et al. Resensitization in suspected #penicillinallergy

Read ? https://t.co/irMhv07kN5

Video abstract of this article ? https://t.co/JIzDlQROYN

Read all recent papers published in #Allergy on #drugallergies ? https://t.co/jUxpXPlxKB @mariajtorresj #Allergy_journal pic.twitter.com/eIB1TdDqPI

— Allergy EAACI (@AllergyEaaci) November 15, 2022

Deconstructing the dogma: meta-analysis of adjunctive gentamicin and rifampin in staphylococcal prosthetic valve endocarditis

2 Feb, 2023 | 15:00h | UTC

Deconstructing the Dogma: Systematic Literature Review and Meta-analysis of Adjunctive Gentamicin and Rifampin in Staphylococcal Prosthetic Valve Endocarditis – Open Forum Infectious Diseases

Commentary on Twitter

So excited to share an #IDTwitter collaborative article!

Together with @Cortes_Penfield @DrToddLee @syctong @DrEmilyMcD @JGPharmD and Irani Thevarajan, we did a systematic review & meta-analysis on gent & rifampin in Staph prosthetic valve endocarditis!https://t.co/XocwPvut3x

— Jonathan Ryder, MD (@JonathanRyderMD) October 31, 2022

Fungal Nomenclature: managing change is the name of the game

2 Feb, 2023 | 14:59h | UTC

Fungal Nomenclature: Managing Change is the Name of the Game – Open Forum Infectious Diseases

Commentary from the author on Twitter (thread – click for more)

Our new article released today in @OFIDJournal, provides an overview and rationale for fungal nomenclature changes, and tips for managing nomenclature change. @ferryhagen @AlirezaAbdolra1 #SAPathology @_Westerdijk_ @KingsCollegeNHS ? 1/https://t.co/lOg5PycjzZ

— Dr. Sarah Kidd (@thefunguskidd) January 7, 2023